CANCER 2025

Refine the list (min. 2 characters)

Keynote Presentation (In-Person)

Rajvir Dahiya, University of California San Francisco School of Medicine , United States

Keynote Presentation (In-Person)

Yan-Shen Shan, Speaker at Oncology Conference

Title: Hypoxia-Fibrosis Cycle in Pancreatic Cancer Reveals Potential Pathways Associated with Tumor Progression and Predicts Poor Prognosis

Pancreatic cancer (PC) is difficult to treat and has the lowest five-year survival rate across the world. PC is characterized by desmoplasia composed of abundant cancer-associated fibroblasts (CAFs) and excessive extracellular matrix (ECM), which creates a pathological barrier th [....] » Read More

Yan-Shen Shan, National Cheng Kung University Hospital, Taiwan

Keynote Presentation (In-Person)

Sergey Suchkov, Speaker at Cancer Science and Research Conference

Title: Personalized and Precision Medicine (PPM) through The View of Biodesign-Inspired Transla-tional Research: An Option for Clinical Oncologists, Caregivers and Consumers to Realize the Potential of Genomics-informed Care to secure the Human Biosafety

A new systems approach to diseased states and wellness result in a new branch in the healthcare services, namely, personalized and precision medicine (PPM). Meanwhile, the era of genomics-based medicine and thus genomics biomarkers promises to provide molecular tests that will pe [....] » Read More

Sergey Suchkov, National Center for Human Photosynthesis, Aguascalientes, Mexico

Keynote Presentation (In-Person)

Thomas J. Webster, Speaker at Cancer Science and Research Conference

Title: Anti-Cancer Nanomedicine in Humans: 30,000 Successful Cases and Counting

This presentation will cover a close to 30 year journey researching and commercializing nanotechnology for improving disease prevention, diagnosis, and treatment (including cancer) which has led to numerous products including nano spinal implants now in over 30,000 patients to da [....] » Read More

Thomas J. Webster, Hebei University of Technology, China

Keynote Presentation (Virtual)

Henrique Manuel dos Santos Faneca, Speaker at Cancer Science and Research Conference

Title: Targeted gene and drug delivery nanosystems to hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is one of the major causes of cancer mortality worldwide, highlighting the urgent need for the development of new therapeutic approaches, such as those involving the combination of gene therapy and chemotherapy, that potentially present higher thera [....] » Read More

Henrique Manuel dos Santos Faneca, University of Coimbra (CNC-UC), Portugal

Keynote Presentation (Virtual)

Julia Sidorova , Speaker at Oncology Conference

Title: Information Leakage: Types, Remedies, and Open problems

Information Leakage threatens and questions the use of machine learning model in real-life clinical applications. In effect, information leakage is similar to vulgar overfitting, yet rather more subtle and even when detected much harder to remove. Some recent research i [....] » Read More

Julia Sidorova , Instituto Carlos III de Salud (CIBER-EHD), Spain

Oral Presentation (In-Person)

Sergey Suchkov, Speaker at Cancer Science and Research Conference

Title: Personalized and Precision Oncology (PPO) to Be Set Up via Precision Oncology Strategy for Can-cer Care Team: Developing Targeted Cancer Therapy & Advancing Personalized Cancer Care

A new systems approach to diseased states and wellness result in a new branch in the healthcare services, namely, personalized and precision medicine (PPM). The concept of PPM is becoming increasingly relevant for cancer treatment, moving from the ‘one-size-fits-all’ [....] » Read More

Sergey Suchkov, National Center for Human Photosynthesis, Aguascalientes, Mexico

Oral Presentation (In-Person)

Ren-Wang Peng, Speaker at Cancer Science and Research Conference

Title: Lactate dehydrogenase B noncanonically promotes ferroptosis defense in KRAS-driven lung cancer

Ferroptosis is an oxidative, non-apoptotic form of cell death that is frequently inactivated in cancer, yet its regulation in oncogene-specific tumors remains poorly understood. Here, we identify lactate dehydrogenase B (LDHB)—but not the closely related LDHA—as a non [....] » Read More

Ren-Wang Peng, University of Bern, Switzerland
To be updated shortly...
To be updated shortly...

Copyright 2024 Mathews International LLC All Rights Reserved

Watsapp
Top